Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bristol-Myers Squibb Company (BMY)

63.97   -1.66 (-2.53%) 02-24 16:00
Open: 64.08 Pre. Close: 65.63
High: 65.06 Low: 63.69
Volume: 11,457,122 Market Cap: 149958M
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 65.244 - 65.606 65.606 - 65.899
Low: 62.567 - 63.081 63.081 - 63.499
Close: 63.215 - 63.976 63.976 - 64.595

Technical analysis

as of: 2020-02-24 4:41:38 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 77.22     One year: 79.82
Support: Support1: 62.51    Support2: 52.01
Resistance: Resistance1: 66.11    Resistance2: 68.34
Pivot: 65.78
Moving Average: MA(5): 65.31     MA(20): 65.31
MA(100): 60.18     MA(250): 52.46
MACD: MACD(12,26): 0.23     Signal(9): 0.49
Stochastic oscillator: %K(14,3): 42.88     %D(3): 52.94
RSI: RSI(14): 42.59
52-week: High: 68.34  Low: 42.48  Change(%): 27.5
Average Vol(K): 3-Month: 1455285  10-Days: 1037977

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BMY has closed above bottom band by 8.1%. Bollinger Bands are 13.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Feb 2020 21:24:51 +0000
After Hours Most Active for Feb 7, 2020 : ABEV, AUY, MSFT, ZNGA, BMY, INTC, KGC, VALE, MRK, QQQ, FB, MU

Sun, 23 Feb 2020 14:32:00 +0000
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease

Sun, 23 Feb 2020 12:31:00 +0000
3 Cancer Treatment Stocks to Buy Right Now

Wed, 19 Feb 2020 19:58:00 +0000
FDA Approved 1,014 Generic Drugs in 2019

Wed, 19 Feb 2020 14:51:39 +0000
Jim Simons: The Investing Guru Bets on These 3 Healthcare Stocks

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2340.00
Shares Float (M) 1630.00
% Held by Insiders 0.10
% Held by Institutions 75.90
Shares Short (K) 67980
Shares Short P. Month (K)

Stock Financials

EPS 2.010
Book Value (p.s.) 10.830
PEG Ratio 0.77
Profit Margin 13.15
Operating Margin 27.16
Return on Assets (ttm)
Return on Equity (ttm) 21.7
Qtrly Rev. Growth 33.0
Gross Profit (p.s.) 8.090
Sales Per Share
EBITDA (p.s.) 3.295
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 31.83
P/E Growth Ratio -0.03
P/BV 5.91
P/S 4.17
P/CF

Dividends & Splits

Dividend 1.680
Dividend Yield 0.03
Dividend Pay Date 2020-02-02
Ex-Dividend Date 2020-01-01
Forward Dividend 1.800
Last Split Date
Last Split Ratio -2.1
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.